Journal
IDCASES
Volume 29, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.idcr.2022.e01578
Keywords
Invasive fungal infection; Invasive mucormycosis; Steroid; COVID-19 associated mucormycosis
Categories
Ask authors/readers for more resources
This study reported a case of disseminated mucormycosis in a COVID-19 patient during hospitalization. The patient experienced severe respiratory failure, intra-abdominal hemorrhage, and septic shock before death.
Background: Since the global outbreak of coronavirus disease 2019 (COVID-19), there have been several reports of mucormycosis as a secondary complication. However, the disseminated type of mucormycosis is extremely rare.Case: A 58-year-old male patient with COVID-19 started receiving venovenous extracorporeal membrane oxygenation because of severe respiratory failure. During hospitalization, intra-abdominal hemorrhage occurred and an emergency laparotomy was performed. Subsequently, the patient suffered septic shock, and part of the small intestines and the abdominal wall became necrotic. Finally, the patient died. At autopsy, he was diagnosed with disseminated mucormycosis.Conclusion: Disseminated mucormycosis should be considered in patients with COVID-19 with refractory sepsis unresponsive to broad-spectrum antimicrobial therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available